Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Can low T3 signaling raise LDL cholesterol even when TSH and free T4 are normal?

Low T3 signaling can increase LDL cholesterol levels despite normal TSH and free T4.

PlausibleJune 19, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Triiodothyronine (T3) increases hepatic LDL receptor expression and LDL clearance, so low T3 signaling can raise LDL cholesterol even when TSH and free T4 are in range.

laying out figure…
6 of 7 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Triiodothyronine drives hepatic LDL receptor production via thyroid receptor–mediated transcription and SREBP-2–linked pathways, which increases LDL clearance. Reduced T3 signaling therefore plausibly lowers receptor-mediated clearance and raises serum LDL, though clinical effects vary across individuals and contexts.

Verified conclusion

Thyroid hormones, specifically triiodothyronine (T3), are fundamental regulators of lipid metabolism. The relationship between T3 and cholesterol is primarily mediated through the liver's ability to clear low-density lipoprotein (LDL) from the blood.

Mechanistic explanations

T3 acts as a potent transcriptional activator for the LDL receptor (LDLR) gene in hepatocytes.

  • Transcriptional Activation: T3 binds to thyroid hormone receptors (TRβ1), which then form heterodimers with retinoid X receptor alpha (RXRα). These complexes bind directly to thyroid hormone response elements (TREs) in the LDLR promoter, inducing the production of LDLR mRNA and protein.
  • SREBP-2 Pathway: T3 also influences LDLR expression indirectly through the sterol regulatory element-binding protein 2 (SREBP-2) pathway, further reinforcing the density of receptors on the hepatocyte surface.
  • LDL Clearance: By increasing the number of active LDL receptors, T3 facilitates the binding and internalization of circulating LDL particles. This process is a primary pathway for maintaining healthy systemic cholesterol levels.

Clinical evidence and implications

While the mechanistic link is well-established, the clinical observation of elevated LDL in patients with "normal" TSH and T4 but low T3 signaling is considered plausible.

  • Low T3 Syndrome: In cases of low T3 syndrome (low FT3 with normal TSH/FT4), research has indicated an inverse relationship between the T3/T4 ratio and total cholesterol. This suggests that as T3 levels drop relative to T4, LDL cholesterol can rise despite "normal" conventional thyroid markers.
  • Variability in Euthyroid Populations: Large-scale studies of healthy, euthyroid individuals (those with TSH in range) have shown mixed results. Some data suggest that lower T3 levels correlate with higher cholesterol, while other cohorts show complex interactions where systemic illness or metabolic dysfunction may play a larger role than thyroid signaling alone.

Bottom line

T3 is a direct driver of hepatic LDL receptor expression and clearance. It is biologically plausible that low T3 signaling can elevate LDL cholesterol even when TSH and T4 are within normal ranges, although the clinical manifestation varies based on individual metabolic health and the presence of non-thyroidal illness.

References

  1. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. — linkinghub.elsevier.com ↗
  2. Using in vivo electroporation to identify hepatic LDL receptor promoter elements and transcription factors mediating activation of transcription by T3 — linkinghub.elsevier.com ↗
  3. Using in vivo electroporation to identify hepatic LDL receptor promoter elements and transcription factors mediating activation of transcription by T3 — pmc.ncbi.nlm.nih.gov ↗
  4. Activation of the hepatic LDL receptor promoter by thyroid hormone. — linkinghub.elsevier.com ↗
  5. Characterization of the rat LDL receptor 5'-flanking region. — linkinghub.elsevier.com ↗
  6. Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism — pmc.ncbi.nlm.nih.gov ↗
  7. Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD — frontiersin.org ↗
  8. Association of Reduced Free T3 to Free T4 Ratio with Lower Serum Creatinine in Japanese Hemodialysis Patients — mdpi.com ↗
  9. Molecular Functions of Thyroid Hormones and Their Clinical Significance in Liver-Related Diseases — pmc.ncbi.nlm.nih.gov ↗
  10. A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→